SmithKline Beckman Corp.: The Philadelphia pharmaceutical company...

SmithKline Beckman Corp.: The Philadelphia pharmaceutical company said second-quarter earnings were $164.8 million, up 28% from a year ago. Sales were up 10% to $1.26 billion. The firm said each of its units contributed to the rise in sales and earnings.